Custom Health Appoints New Executive Leadership Team
The company adds two veteran executives to spearhead its North American expansion strategy.
Updated on Oct. 21, 2026 in People
Live Poll
Do you trust AI-enabled platforms to manage your healthcare and medication needs accurately?
Custom Health has appointed Mike Palackdharry as Chief Commercial and Strategy Officer and Christina Garcia as Chief Compliance and Regulatory Officer. These leadership additions support the company's ongoing expansion of its medication management platform throughout North America.
Why it matters
Strengthening leadership in commercial strategy and regulatory compliance allows the organization to scale its operations effectively within the complex healthcare sector. These appointments are designed to bolster the firm's governance and sales capabilities during a period of growth.
The new leadership team brings significant industry tenure, with Palackdharry contributing over 30 years of business experience and Garcia offering more than 15 years in healthcare compliance.
The players
Mike Palackdharry
He is the new Chief Commercial and Strategy Officer at Custom Health with three decades of experience in business development and strategy.
Christina Garcia
She joins as the Chief Compliance and Regulatory Officer at Custom Health after spending 15 years in the healthcare compliance sector.
Custom Health
This organization operates a medication management platform and is currently scaling its footprint across North American markets.
The details
Mike Palackdharry will manage enterprise sales, business development, go-to-market design, and strategic partnerships. Meanwhile, Christina Garcia will take charge of the company's enterprise privacy, governance, and compliance functions.
Timeline
October 22, 2026: Custom Health closes the Toronto Stock Exchange.
Market Landscape
These executive hires align with the ongoing expansion of digital health medication management platforms across North America. The move positions the company to compete more aggressively by formalizing its strategic and regulatory frameworks as it captures greater market share.
The appointment of specialized leadership suggests that customers can expect more robust service offerings and improved regulatory oversight in their medication management experiences. These organizational changes do not directly alter consumer pricing or subscription access at this time.
The takeaway
Adding veteran expertise to commercial and compliance roles is a standard strategy for firms navigating the transition from startup growth to enterprise maturity. Stakeholders should monitor how these leadership changes influence the company's operational speed and service expansion in the coming year.
Further reading
For more updates on corporate personnel changes, visit the Canada People section.
Live Poll
Do you trust AI-enabled platforms to manage your healthcare and medication needs accurately?
